Pharma IQ Exclusive with CDISC's Rebecca Kush: The Role of the Clinical Data Manager in an Automated e-Future




Rebecca Daniels Kush, Ph.D. is a Founder and the current President and CEO of CDISC, speaks to Andrea Chares from Pharma IQ, about how eSource guidance is generating a lot of discussion and opportunity, improving e-submissions, making standards more accessible and how to better link healthcare and research.

[inlinead]

Rebecca Daniels Kush, Ph.D. is a Founder and the current President and CEO of CDISC. Dr. Kush has over 25 years of experience in the area of clinical research. She has worked for the U.S. National Institutes of Health, academia, a global contract research organization and pharmaceutical companies in the U.S. and Japan.  Among numerous publications, Dr. Kush is lead author of the book, eClinical Trials: Planning and Implementation. Dr. Kush has given invited presentations (including keynotes) and tutorials at industry conferences, FDA and other venues in the U.S., Europe, and Japan for over 20 years. She earned a Ph.D. in Physiology and Pharmacology from the University of California (UCSD) School of Medicine in La Jolla, CA and has a B.S. in Chemistry and Biology from the University of New Mexico.

Rebecca Daniels Kush, Ph.D. is a Founder and the current President and CEO of CDISC, speaks to Andrea Chares from Pharma IQ, about how eSource guidance is generating a lot of discussion and opportunity, improving e-submissions, making standards more accessible and how to better link healthcare and research.